Clinical Trials Browser

Phase 3 × elacestrant × Breast × Clear all

NCT07242352 2025-11-21

ADAPTela

Phase 3 Not yet recruiting

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT05512364 2025-08-19

TREAT ctDNA

Phase 3 Recruiting

Breast Neoplasms